Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

ChemPartner Adds B Cell Discovery from Berkeley Lights to Offerings

publication date: May 17, 2019

Shanghai ChemPartner, a China CRO, extended its collaboration with Berkeley Lights Inc. of South San Francisco by installing BLI's Beacon® Optofluidic platform to offer B Cell antibody discovery services to its clients. ChemPartner will combine BLI's antibody discovery workflow for B cells with ChemPartner's assays. The Beacon® platform can screen tens of thousands of plasma B cells or gene-edited cells automatically, speeding up a usually time-consuming process. The Beacon® platform enables plasma B cell characterization in less than a day. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital